Our top pick for
GLADL is an other business based in the US. GLADL shares (GLADL) are listed on the NASDAQ and all prices are listed in US Dollars.
|52-week range||USD$13.9215 - USD$26.9|
|50-day moving average||USD$25.7491|
|200-day moving average||USD$25.2097|
|Wall St. target price||N/A|
|Dividend yield||N/A (6.73%)|
|Earnings per share (TTM)||USD$0.8261|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing GLADL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GLADL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GLADL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, GLADL shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Gross profit TTM||USD$0|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
TTM: trailing 12 months
There are currently 615 GLADL shares held short by investors – that's known as GLADL's "short interest". This figure is 17.2% down from 743 last month.
There are a few different ways that this level of interest in shorting GLADL shares can be evaluated.
GLADL's "short interest ratio" (SIR) is the quantity of GLADL shares currently shorted divided by the average quantity of GLADL shares traded daily (recently around inf billion). GLADL's SIR currently stands at 0. In other words for every 100,000 GLADL shares traded daily on the market, roughly 0 shares are currently held short.
However GLADL's short interest can also be evaluated against the total number of GLADL shares, or, against the total number of tradable GLADL shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GLADL's short interest could be expressed as 0% of the outstanding shares (for every 100,000 GLADL shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable GLADL shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GLADL.
Find out more about how you can short GLADL stock.
Dividend payout ratio: 112.94% of net profits
Recently GLADL has paid out, on average, around 112.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.73% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), GLADL shareholders could enjoy a 6.73% return on their shares, in the form of dividend payments. In GLADL's case, that would currently equate to about $N/A per share.
GLADL's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
GLADL's most recent dividend payout was on 1 November 2021.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.